RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis
Mar 2011 - 4 pages - $500
Liver Fibrosis - Pipeline Review, Q4 2010
Dec 2010 - 29 pages - $500
ORG Informatics Limited (517195) - Strategic SWOT Analysis Review
May 2011 - 15 pages - $125
Liver Fibrosis Global Clinical Trials Review, Q1, 2011
Apr 2011 - 57 pages - $1,000
CREDIT ORG OF S&M ENTPRS (8489) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $125
Union Memorial Hospital - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Liver Fibrosis Global Clinical Trials Review, H2, 2011
Sep 2011 - 83 pages - $1,000
Refractive Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Dec 2010 - 67 pages - $3,500
Bumrungrad Hospital Public Company Limited: SWOT Analysis & Company Profile
Jun 2010 - 22 pages - $99
Spinal Surgery Devices Global Market Briefing to 2016
Sep 2010 - 29 pages - $2,000
More Related Market Research Reports >>>

Your selection

Industry sector
Non-profit org./Government del
Reference sources del
Therapeutic target
Hospital and Surgery del
Fibrosis del
Year
2002 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us